Cosm Medical is a healthcare startup based in Canada that aims to revolutionize the field of female pelvic health. With a mission to address the significant financial burden and prevalence of pelvic health issues, such as incontinence and pelvic organ prolapse, the company has attracted attention from investors. In its most recent funding round in April 2022, Cosm Medical secured a substantial $4.70M in Seed Round investment from a noteworthy group of investors, including Fusion Fund, MaRS IAF, iGan Partners, Archangel Network of Funds, The Archangel Fund, and TELUS Pollinator Fund for Good. The company's flagship product, Gynethotics™ pessaries, represents the world’s first personalized gynecological prosthetic. Additionally, Cosm Medical is developing a digital gynecology platform that utilizes innovative diagnostics, AI, cloud software, and 3D printing to create patient-specific gynecological devices. This approach not only represents a significant leap in personalized healthcare but also presents expansive opportunities to enhance the continuum of pelvic care for women, covering needs from obstetrics to elderly care. As a 2017 startup operating within the Health Care industry, Cosm Medical is positioned at the intersection of cutting-edge technology, healthcare innovation, and personalized medicine, making it an intriguing prospect for investors seeking to support transformative solutions in women's health. With a strong focus on addressing a pressing healthcare issue and leveraging advanced technology, Cosm Medical shows promise in shaping the future of digital gynecology and personalized pelvic health care.
No recent news or press coverage available for Cosm Medical.